US 7358258
Prodrugs of an ERK protein kinase inhibitor
granted A61PA61P1/16A61P11/06
Quick answer
US patent 7358258 (Prodrugs of an ERK protein kinase inhibitor) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P1/16, A61P11/06, A61P17/06, A61P19/08